Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 131

1.

[Effect of evidence-based medicine on the decision of chemotherapy for epithelial ovarian cancer].

Li GT.

Zhonghua Fu Chan Ke Za Zhi. 2012 Aug;47(8):582-6. Chinese. No abstract available.

PMID:
23141177
[PubMed - indexed for MEDLINE]
2.

Chemotherapy for ovarian cancer: an evidence-based approach.

Geisler JP, Manahan KJ, Wiemann MC.

Minerva Ginecol. 2004 Dec;56(6):539-45. Review.

PMID:
15729206
[PubMed - indexed for MEDLINE]
3.

Future directions in the chemotherapy of ovarian cancer.

Ozols RF.

Semin Oncol. 1997 Oct;24(5 Suppl 15):S15-86-S15-90. Review.

PMID:
9346230
[PubMed - indexed for MEDLINE]
4.

Paclitaxel with carboplatin versus paclitaxel with carboplatin alternating with cisplatin as first-line chemotherapy in advanced epithelial ovarian cancer: preliminary results of a Hellenic Cooperative Oncology Group study.

Skarlos DV, Aravantinos G, Kosmidis P, Athanassiadis A, Stathopoulos GP, Pavlidis N, Bafaloukos D, Karphathios S, Papakostas P, Bamia C, Fountzilas G.

Semin Oncol. 1997 Oct;24(5 Suppl 15):S15-57-S15-61.

PMID:
9346224
[PubMed - indexed for MEDLINE]
5.

Neoadjuvant chemotherapy followed by interval cytoreductive surgery in patients with unresectable, advanced stage epithelial ovarian cancer: a single centre experience.

Bilici A, Salepci T, Dane F, Gumus M, Ustaalioglu BB, Seker M, Salman T, Turan C, Unal O, Yaylaci M.

Arch Gynecol Obstet. 2010 Oct;282(4):417-25. doi: 10.1007/s00404-009-1330-7. Epub 2009 Dec 25.

PMID:
20035339
[PubMed - indexed for MEDLINE]
6.

Role of chemotherapy in epithelial ovarian cancer.

Markman M.

Minerva Ginecol. 2011 Jun;63(3):287-97.

PMID:
21654613
[PubMed - indexed for MEDLINE]
7.

Neoadjuvant chemotherapy (NACT) is an effective way of managing elderly women with advanced stage ovarian cancer (FIGO Stage IIIC and IV).

Glasgow MA, Yu H, Rutherford TJ, Azodi M, Silasi DA, Santin AD, Schwartz PE.

J Surg Oncol. 2013 Feb;107(2):195-200. doi: 10.1002/jso.23171. Epub 2012 May 30.

PMID:
22648987
[PubMed - indexed for MEDLINE]
8.

Patterns of chemotherapy treatment for women with invasive epithelial ovarian cancer--a population-based study.

Jordan S, Steer C, DeFazio A, Quinn M, Obermair A, Friedlander M, Francis J, O'Brien S, Goss G, Wyld D, Australian Ovarian Cancer Study Group, Webb P; Ovarian Cancer Patterns of Care Study Group.

Gynecol Oncol. 2013 May;129(2):310-7. doi: 10.1016/j.ygyno.2013.02.007. Epub 2013 Feb 9.

PMID:
23403164
[PubMed - indexed for MEDLINE]
9.

Chemotherapy for recurrent ovarian cancer.

Kaye SB.

Lancet. 2003 Jun 21;361(9375):2094-5. No abstract available.

PMID:
12826426
[PubMed - indexed for MEDLINE]
10.
11.

Does intraperitoneal chemotherapy benefit optimally debulked epithelial ovarian cancer patients after neoadjuvant chemotherapy?

Le T, Latifah H, Jolicoeur L, Weberpals J, Faught W, Hopkins L, Fung MF.

Gynecol Oncol. 2011 Jun 1;121(3):451-4. doi: 10.1016/j.ygyno.2011.02.016. Epub 2011 Mar 12.

PMID:
21402403
[PubMed - indexed for MEDLINE]
12.

Intraperitoneal cisplatin therapy in ovarian cancer: comparison with standard intravenous carboplatin and paclitaxel.

Ozols RF, Bookman MA, du Bois A, Pfisterer J, Reuss A, Young RC.

Gynecol Oncol. 2006 Oct;103(1):1-6. Epub 2006 Aug 10. No abstract available.

PMID:
16904166
[PubMed - indexed for MEDLINE]
13.

[Value of CA(125) in the prediction of optimal interval debulking surgery and its prognosis in patients with epithelial ovarian cancer].

Mu T, Li XP, Wang JL, Wang SJ, Wang Y, Sun XL, Cui H, Wei LH.

Zhonghua Fu Chan Ke Za Zhi. 2012 Aug;47(8):566-70. Chinese.

PMID:
23141174
[PubMed - indexed for MEDLINE]
14.

Efficacy and safety of the combination paclitaxel/carboplatin in patients with previously treated advanced ovarian carcinoma: a multicenter French Groupe des Investigateurs Nationaux pour l'Etude des Cancers Ovariens phase II study.

Pujade-Lauraine E, Guastalla JP, Weber B, Curé H, Orfeuvre H, Mousseau M, Vincent P, Diéras V, Tubiana-Mathieu N, Jacquin JP, Mignot L, Leduc B, Paraïso D, Viens P.

Semin Oncol. 1997 Oct;24(5 Suppl 15):S15-30-S15-35.

PMID:
9346219
[PubMed - indexed for MEDLINE]
15.

Feasibility of intraperitoneal chemotherapy in advanced epithelial ovarian cancer.

Maheshwari A, Gupta S, Prabhash K, Tongaonkar HB.

Indian J Cancer. 2010 Apr-Jun;47(2):225-6. doi: 10.4103/0019-509X.63007. No abstract available.

PMID:
20448394
[PubMed - indexed for MEDLINE]
Free Article
16.

[Combined pegylated liposomal doxorubicin and carboplatin in the treatment of recurrent epithelial ovarian cancer].

Zheng H, Gao YN, Jiang GQ, Gao M, Wang W, Yan X.

Zhonghua Fu Chan Ke Za Zhi. 2008 Nov;43(11):839-42. Chinese.

PMID:
19087568
[PubMed - indexed for MEDLINE]
17.

Ovarian cancer: front-line standard treatment in 2008.

Vasey PA.

Ann Oncol. 2008 Sep;19 Suppl 7:vii61-6. doi: 10.1093/annonc/mdn479. No abstract available.

PMID:
18790981
[PubMed - indexed for MEDLINE]
Free Article
18.

An update on the use of intraperitoneal chemotherapy in the management of ovarian cancer.

Markman M.

Cancer J. 2009 Mar-Apr;15(2):105-9. doi: 10.1097/PPO.0b013e31819e31f2. Review.

PMID:
19390303
[PubMed - indexed for MEDLINE]
19.

Medical treatment of epithelial ovarian cancer.

González-Martín AJ.

Expert Rev Anticancer Ther. 2004 Dec;4(6):1125-43. Review.

PMID:
15606338
[PubMed - indexed for MEDLINE]
20.

Dose-escalated paclitaxel in 1-hour infusion with a fixed dose of cisplatin in previously untreated advanced ovarian cancer: a phase II trial of the Spanish Group for Ovarian Cancer.

Cervantes A, Mendiola C, del Campo JM, Massuti B, Casado A, Escobedo A, Moyano A, Ojeda B, Poveda A, Benito D.

Semin Oncol. 1997 Oct;24(5 Suppl 15):S15-40-S15-43.

PMID:
9346221
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk